Simplifying Global Compliance
The QMN Weekly Bulletin
FDA Releases Warning Letter on Novartis Violations
Dec. 9, 2011
The FDA released a warning letter it sent to Novartis AG last month, which said the drug maker’s generic-drug unit so far has failed to correct repeated manufacturing violations.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing